Skip to main content
. 2022 Mar 26;11(7):1835. doi: 10.3390/jcm11071835

Table 1.

Characteristics of patients with liver cirrhosis.

Variable Total (n = 99) Chronic Hepatitis (n = 15) Liver Cirrhosis
Child–Pugh Class A (n = 25) Child–Pugh Class B (n = 23) Child–Pugh Class C (n = 36)
Age (year) 67 (60–74) 60 (51–67) 72 (68–76) * 64 (58–68) 69 (61–74) *
Sex (male/female) 63/36 9/6 19/6 14/9 21/15
Etiology (HBV/HCV/Alcohol/NASH/PBC/unknown) 12/67/10/6/3/1 0/15/0/0/0/0 1/18/4/2/0/0 6/15/1/1/0/0 5/19/5/3/3/1
Albumin (g/dL) 3.2 (2.8–3.8) 4.2 (3.9–4.5) 3.4 (3.1–4.1) * 3.2 (2.9–3.4) ** 2.7 (2.5–3.0) ***
Aspartate aminotransferase (IU/L) 52 (38–76) 39 (31–48) 52 (38–64) 56 (41–89) 63 (38–85)
Alanine aminotransferase (IU/L) 42 (26–58) 50 (35–61) 38 (27–55) 45 (30–60) 32 (23–53)
Prothrombin time (%) 75 (53–89) 98 (94–105) 83 (80–92) * 71 (64–84) ** 50 (38–57) ***
Blood urea nitrogen (mg/dL) 17 (12–26) 13 (10–15) 16 (10–20) 16 (14–22) * 26 (16–45) ***
Creatinine (mg/dL) 0.8 (0.7–1.1) 0.8 (0.6–0.8) 0.8 (0.7–0.9) 0.7 (0.6–1.0) 1.0 (0.7–1.5) *, **
Total bilirubin (mg/dL) 1.6 (0.8–2.6) 0.6 (0.5–1.4) 1.0 (0.7–1.3) * 1.6 (0.9–1.9) ** 3.4 (2.3–5.3) ***
White blood cell count (/mm3) 4400 (2975–6200) 5200 (3700–6150) 4400 (2900–5500) 3750 (2575–5100) 5250 (3300–8175)
Hemoglobin (g/dL) 11.4 (9.6–12.8) 14.0 (12.1–15.5) 12.0 (11.1–12.8) * 12.2 (10.9–13.0) 9.0 (7.7–10.9) ***
Platelet count (×104/mm3) 7.7 (5.9–11.0) 14.2 (9.7–17.2) 9.2 (7.6–12.7) * 6.4 (5.2–8.3) ** 6.4 (4.8–7.7) **
Ascites (none/mild to moderate/severe) 62/12/25 15/0/0 25/0/0 14/7/2 ** 8/5/23 ***
Hepatorenal syndrome (with/without) 9/90 0/15 0/25 1/22 8/28 ***
Encephalopathy (with/without) 37/62 0/15 0/25 7/16 ** 30/6 ***
Esophageal varices (with/without) 65/34 0/15 16/9 * 19/4 * 30/6 *
Hepatocellular carcinoma (with/without) 46/53 1/14 17/8 * 12/11 * 16/20 *

* p < 0.05 between chronic hepatitis and Child–Pugh class A, B, or C; ** p < 0.05 between Child–Pugh classes A and B or C; *** p < 0.05 between Child–Pugh classes B and C; data are expressed as medians (interquartile ranges); HBV, hepatitis B virus; HCV, hepatitis C virus; NASH, nonalcoholic steatohepatitis; PBC, primary biliary cholangitis.